Adapalene gel 0.1% vs ketoconazole cream 2% and their combination in treatment of pityriasis versicolor: A randomized clinical study

Dermatol Ther. 2020 May;33(3):e13319. doi: 10.1111/dth.13319. Epub 2020 Mar 30.

Abstract

Pityriasis versicolor (PV) is a chronic superficial fungal infection. Management using azole drugs leads to drug resistance. The present study aimed to compare the clinical outcome of 0.1% adapalene gel vs 2% ketoconazole cream and their combination in PV. This randomized double-blinded study was conducted on 90 PV patients divided into three equal groups. GI was treated with topical ketoconazole 2% cream twice daily and placebo, GII was treated with topical 0.1% adapalene gel twice daily and placebo and GIII was treated with topical combination of 0.1% adapalene gel (at night) and ketoconazole 2% cream (in the morning). All patients received medications for 4 weeks. Evaluation was done at 2 and 4 weeks and included clinical assessment, laboratory assessment, and patient satisfaction. We found that after 4 weeks of treatment, all groups showed significant improvement. There was better response in GIII in terms of lower rate of positive potassium hydroxide staining, higher rate of significantly improved cases and higher rate of well-satisfied patients. However, the difference fell short of statistical significance. We concluded that a combination of adapalene gel and ketoconazole cream is very effective in treatment of PV with no or mild side effects.

Keywords: adapalene; ketoconazole; pityriasis versicolor.

Publication types

  • Randomized Controlled Trial

MeSH terms

  • Acne Vulgaris* / drug therapy
  • Adapalene
  • Dermatologic Agents* / adverse effects
  • Gels
  • Humans
  • Ketoconazole / adverse effects
  • Ointments
  • Tinea Versicolor* / diagnosis
  • Tinea Versicolor* / drug therapy
  • Treatment Outcome

Substances

  • Dermatologic Agents
  • Gels
  • Ointments
  • Adapalene
  • Ketoconazole